[
  {
    "comment": "FMN is re-reduced by NADH (see R05705)", 
    "definition": "3-Hydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione + Reduced FMN + Oxygen <=> 3,4-Dihydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione + FMN + H2O", 
    "orthologs": {
      "K16048": "3-hydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione monooxygenase reductase component [EC:1.5.1.-]", 
      "K16047": "3-hydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione monooxygenase [EC:1.14.14.12]"
    }, 
    "name": "3-hydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione,FMNH2:oxygen oxidoreductase", 
    "product_stoichiometries": [
      "1", 
      "1", 
      "1"
    ], 
    "enzymes": [
      "1.14.14.12"
    ], 
    "equation": "C19944 + C01847 + C00007 <=> C04793 + C00061 + C00001", 
    "glycans": false, 
    "substrate_stoichiometries": [
      "1", 
      "1", 
      "1"
    ], 
    "rpairs": {}, 
    "entry_id": "R09819", 
    "pathways": {
      "rn00984": "Steroid degradation", 
      "rn01120": "Microbial metabolism in diverse environments", 
      "rn01100": "Metabolic pathways"
    }, 
    "products": [
      "C04793", 
      "C00061", 
      "C00001"
    ], 
    "substrates": [
      "C19944", 
      "C01847", 
      "C00007"
    ]
  }
]